Expansion of Pharmaceutical Firm in Philadelphia to Create Over 150 Jobs
09/07/2011
The move should be complete by fourth quarter 2012. Currently the firm takes up 19,000-sq.-ft. of space at the corporate facility.
Founded in 2006, Iroko specializes in nanoformulation technology used to to create improved versions of existing nonsteroidal, anti-inflammatory drugs.
Iroko President/CEO John Vavricka said his company needs the additional room to prepare for the anticipated launch of a new drug product, slated for 2013. "We've run out of space," he said. "Launching a product in the United States is going to require a much larger footprint."
Iroko was initially drawn to the location due to the numerous advantages Philadelphia offers life sciences businesses, such as its "highly educated workforce and research infrastructure," said a company official.
Project Announcements
France-Based Sartorius Stedim Plans Marlborough, Massachusetts, Bioprocess Operations
12/10/2024
357 Brewers Expands Myrtle Beach, South Carolina, Operations
12/05/2024
Koch Foods Expands Morton, Mississippi, Operations
12/04/2024
Irving Tissue Expands Macon, Georgia, Production Operations
12/03/2024
General Mills Expands Hannibal, Missouri, Production Operations
12/03/2024
US Foods Expands Buda, Texas, Distribution Operations
12/03/2024
Most Read
-
How Automation Is Actually Closing the Labor Gap
Q4 2024
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
The Role of Rail in Industrial Development
Q4 2024
-
Hydrogen Industry in Canada: A Global Leader in the Clean Energy Revolution
Q3 2024
-
Which AI Tools Work for Job Recruiters?
Q3 2024
-
Permitted Power Capacity Foreshadows Health of Regional Economies
Q3 2024
-
Navigating Non-Disclosure Agreements in Site Selection
Q3 2024